An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.

The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.

Read the full article

References

Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).

Share this

Related Posts

The Deaflympics Receives Sport and Performance Psychology Support

Support for Congenital Cytomegalovirus Screenings

Some Fish Hear with Their Bones and Communicate in an Unusual Way

Recent Posts

Discover What’s New (and Worth the Trip) at AAA 2026

We’re gearing up for an unforgettable convention, and we’re excited to share what’s new in San Antonio! This year’s convention brings fresh programming, expanded learning…

Read More

Congress Introduces Legislation to Protect Audiology Students’ Access to Federal Loans

New bipartisan legislation (H.R. 6718) introduced in the U.S. House of Representatives would restore audiology to the federal definition of a professional degree under the…

Read More

Academy Presents Inaugural AAA National Health Leadership Award to Representative Bilirakis

Today, Patrick Gallagher, Executive Director of the American Academy of Audiology, presented the inaugural AAA National Hearing Health Leadership Award to Representative Gus Bilirakis (R-FL)…

Read More